Fox Business - The Power to Prosper
Search Site

Biotechnology

Morning Business Outlook: 4/7/14

'Temp jobs' now make up 2.5 percent of the workforce

Read More

  1. Will hedge funds get burned by inversion deals?

    Liz Hoffman of The Wall Street Journal discusses how Treasury Secretary Jack Lew’s new measures to discourage inversion deals impacts mergers and hedge funds.

  2. Google on the cutting edge of innovation

    Former Google CEO Eric Schmidt and former Google executive Jonathan Rosenberg discuss the company’s mobile and advertising strategy, and innovation in healthcare.

  3. Treasury takes aim at corporate inversion

    FBN’s Liz MacDonald on deal stocks under pressure as the U.S. announces stricter tax rules.

  4. Demandware shares a ‘buy’ or too risky?

    FBN’s Charles Payne, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall and FBN’s Tracy Byrnes on the outlook for Demandware.

  5. Don’t hold your breath: Politics could hold up iPhone 6 in China

    Gerber Kawasaki CEO Ross Gerber and Permanent Portfolio Family of Funds CEO Michael Cuggino explain how the iPhone 6 might not be available in China until the end of the year.

  6. Stocks to watch: COH, SYMC

    See It Market Strategist Ryan Detrick, Al Frank Asset Management CIO John Buckingham and SFG Alternatives CIO Larry Shover on the outlook for stocks.

  7. Stocks to watch: CMG, DIS

    Rosenthal Wealth Management Group President Larry Rosenthal, Spectrum Management Group Managing Partner Bob Phillips, OptionPit.com founder Mark Sebastian and FBN’s Nicole Petallides on the state of the markets.

  8. Byron Wien hot on tech, biotech

    Blackstone Advisory Partners vice chairman Byron Wien discusses the rise in company buybacks and his outlook for the markets.

  9. Leading the way for biotech

    Quintiles CEO Tom Pike talks business in the biotech industry.

  10. Apple announcement’s impact on the tech sector

    Veracruz founder Steve Cortes weighs in on the possible implications following Tuesday’s Apple announcement.

  11. Stossel 07/31/14: Let us experiment

    Stossel and his family members talk about out-of-the-ordinary things they've tried

  12. The future of 3D-organ-tissue printing

    Organovo Holdings Chief Strategy Officer Dr. Eric Michael David on a $20,000 hospital bill and 3D organ tissue printing.

  1. Morning Business Outlook: 4/11/14

    IRS reports tax return identity theft increase

  2. Hong Kong’s global impact

    Alger CEO Daniel Chung and Haverford Trust CIO Hank Smith discuss how Hong Kong impacts how you allocate capital.

  3. Buy the emerging markets

    Portfolio Wealth Advisors CIO Lee Munson gives insight into the markets.

  4. Is housing a tailwind for the economy?

    Alger CEO Daniel Chung and Haverford Trust CIO Hank Smith give insight into the markets and economy.

  5. Hot action in Ebola stocks

    FBN’s Liz MacDonald on investors backing companies that are developing drugs to combat the Ebola virus.

  6. PayPal’s Thiel: Bet on nuclear

    PayPal Co-founder Peter Thiel on the push for transparency in China and the future of energy.

  7. Illumina shares a way for investors to gain from biotech sector?

    FBN’s Charles Payne, Empyrion Wealth Management President Kimberly Foss, A&G Capital CIO Hilary Kramer, retail analyst Hitha Prabhakar, Penn Financial Group founder Matt McCall and FBN’s Tracy Byrnes on the outlook for Illumina.

‹ Prev12345Next ›
Freebase CC-BY
Source: Biotechnology on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL